Community post

The Phage Australia Clinical Network has published the STAMP Protocol for phage therapy. This is an open-label, single-arm trial investigating a standardised treatment and monitoring protocol for phage therapy. The aim is to recruit 50–100 patients over 5 years, from any public or private hospitals in Australia. The primary outcome is safety at day 29. Secondary outcomes include long-term safety (6 months+ following phage therapy), and feasibility, measured as the proportion of participants with >80% of minimum data available for analysis.